TEX9

gene
On this page

Summary

TEX9 (testis expressed 9, HGNC:29585) is a protein-coding gene on chromosome 15q21.3, encoding Testis-expressed protein 9 (Q8N6V9).

Located in centriolar satellite.

Source: NCBI Gene 374618 — RefSeq curated summary.

At a glance

  • GWAS associations: 24
  • Clinical variants (ClinVar): 83 total
  • MANE Select transcript: NM_001395496

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29585
Approved symbolTEX9
Nametestis expressed 9
Location15q21.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000151575
Ensembl biotypeprotein_coding
OMIM620935
Entrez374618

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 12 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000352903, ENST00000537232, ENST00000558083, ENST00000558127, ENST00000559142, ENST00000559546, ENST00000560582, ENST00000560827, ENST00000561221, ENST00000696102, ENST00000876251, ENST00000876252, ENST00000876253, ENST00000931689, ENST00000931690, ENST00000956901, ENST00000956902

RefSeq mRNA: 16 — MANE Select: NM_001395496 NM_001286449, NM_001385040, NM_001385041, NM_001385042, NM_001385043, NM_001385044, NM_001385045, NM_001385046, NM_001385047, NM_001385048, NM_001385049, NM_001385050, NM_001385051, NM_001385052, NM_001395496, NM_198524

CCDS: CCDS10157, CCDS66776

Canonical transcript exons

ENST00000696102 — 12 exons

ExonStartEnd
ENSE000011033525638931856389400
ENSE000011837535638847256388520
ENSE000025481955639124356391418
ENSE000039659955641230256412436
ENSE000039659975642836756430154
ENSE000039659985636542656365477
ENSE000039659995638395256384031
ENSE000039660005642760556427739
ENSE000039660025636557956365670
ENSE000039660035637344156373504
ENSE000039660055639466156394834
ENSE000039660065639416556394247

Expression profiles

Bgee: expression breadth ubiquitous, 192 present calls, max score 94.91.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5030 / max 161.5657, expressed in 1266 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1467895.03561246
1467900.169853
1467930.148964
1467910.081335
1467920.067428

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370194.91gold quality
right uterine tubeUBERON:000130294.01gold quality
bronchial epithelial cellCL:000232893.25gold quality
bronchusUBERON:000218591.58gold quality
olfactory segment of nasal mucosaUBERON:000538689.62gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.48gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.24gold quality
ventricular zoneUBERON:000305384.74gold quality
oocyteCL:000002383.72gold quality
adenohypophysisUBERON:000219683.20gold quality
mucosa of paranasal sinusUBERON:000503083.14gold quality
ganglionic eminenceUBERON:000402382.82gold quality
secondary oocyteCL:000065581.63gold quality
pituitary glandUBERON:000000781.44gold quality
right testisUBERON:000453481.40gold quality
left testisUBERON:000453381.10gold quality
testisUBERON:000047380.80gold quality
fallopian tubeUBERON:000388980.39gold quality
metanephros cortexUBERON:001053379.86gold quality
islet of LangerhansUBERON:000000679.39gold quality
minor salivary glandUBERON:000183078.94gold quality
oviduct epitheliumUBERON:000480478.93gold quality
bone marrow cellCL:000209277.26gold quality
adrenal tissueUBERON:001830376.97gold quality
left lobe of thyroid glandUBERON:000112076.82gold quality
rectumUBERON:000105276.81gold quality
thyroid glandUBERON:000204676.71gold quality
gall bladderUBERON:000211076.65gold quality
right adrenal gland cortexUBERON:003582776.40gold quality
left adrenal gland cortexUBERON:003582576.26gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.64
E-MTAB-6058no296.66

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting TEX9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-579-3P99.8671.663628
HSA-MIR-469899.8471.414303
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-4639-5P99.8167.371028
HSA-MIR-430699.7270.503630
HSA-MIR-715099.6266.801322
HSA-MIR-432899.5771.064094
HSA-MIR-185-5P99.3568.602497
HSA-MIR-464499.3569.122514
HSA-MIR-570198.9769.541502
HSA-MIR-990398.4766.70748
HSA-MIR-1199-5P98.4466.51829
HSA-MIR-6751-3P98.4466.35835
HSA-MIR-64098.4466.93644
HSA-MIR-6516-5P98.4270.191551
HSA-MIR-561-5P98.2568.131365
HSA-MIR-6880-5P98.0865.591282
HSA-MIR-473697.9665.891287
HSA-MIR-392197.8167.451431
HSA-MIR-366597.7365.08975
HSA-MIR-56297.6665.63698
HSA-MIR-4670-3P97.3768.351378
HSA-MIR-4653-5P97.2267.721429
HSA-MIR-125A-3P97.0466.92902
HSA-MIR-345-5P96.4066.43663
HSA-MIR-644A96.0266.52786

Literature-anchored findings (GeneRIF, showing 1)

  • Testis-expressed protein 9 (TEX9) expression is positively associated with eukaryotic translation initiation factor 3 subunit b (eIF3b) expression in esophageal squamous cell carcinoma (ESCC). TEX9 expression is positively correlated with tumor-node-metastasis stage in ESCC. eIF3b binding to TEX9 mRNA functionally synergizes to promote the proliferation and migration, and inhibit the apoptosis of ESCC cells. (PMID:31481019)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotex9ENSDARG00000010586
mus_musculusTex9ENSMUSG00000090626
rattus_norvegicusTex9ENSRNOG00000059702
drosophila_melanogasterCG4681FBGN0069913

Protein

Protein identifiers

Testis-expressed protein 9Q8N6V9 (reviewed: Q8N6V9)

All UniProt accessions (9): Q8N6V9, A0A0S2Z5Z9, A0A0S2Z669, A0A0S2Z6S1, H0YKG1, H0YLZ3, H0YM20, H0YND2, H3BS88

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite.

Isoforms (2)

UniProt IDNamesCanonical?
Q8N6V9-11yes
Q8N6V9-22

RefSeq proteins (16): NP_001273378, NP_001371969, NP_001371970, NP_001371971, NP_001371972, NP_001371973, NP_001371974, NP_001371975, NP_001371976, NP_001371977, NP_001371978, NP_001371979, NP_001371980, NP_001371981, NP_001382425, NP_940926 (=MANE)

Domains & families (InterPro)

UniProt features (5 total): region of interest 2, chain 1, coiled-coil region 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N6V9-F178.740.54

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 106 (showing top): SHEPARD_BMYB_MORPHOLINO_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_CENTROSOME, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP, RFX1_02, GATA4_Q3, GOCC_CENTRIOLAR_SATELLITE, MATSUDA_NATURAL_KILLER_DIFFERENTIATION, BRUINS_UVC_RESPONSE_LATE, ESC_V6.5_UP_EARLY.V1_UP, GSE14415_INDUCED_VS_NATURAL_TREG_DN, BANP_TARGET_GENES, DYRK1A_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): centriolar satellite (GO:0034451), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
binding1
centrosome1
intracellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

470 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TEX9CCDC112Q8NEF3584
TEX9C10orf88Q9H8K7556
TEX9CCDC60Q8IWA6543
TEX9FAXCQ5TGI0542
TEX9CCDC14Q49A88490
TEX9UTP3Q9NQZ2485
TEX9SPAG17Q6Q759479
TEX9TEX19Q8NA77447
TEX9CCDC13Q8IYE1441
TEX9SPATA4Q8NEY3438
TEX9KIAA0753Q2KHM9436
TEX9TEX26Q8N6G2435
TEX9SPATC1LQ9H0A9434
TEX9BIVMQ86UB2424
TEX9TEX22C9J3V5418

IntAct

46 interactions, top by confidence:

ABTypeScore
KDM1ATEX9psi-mi:“MI:0915”(physical association)0.670
TEX9CCDC112psi-mi:“MI:0915”(physical association)0.630
CCDC112TEX9psi-mi:“MI:0915”(physical association)0.630
TEX9GOLGA2psi-mi:“MI:0915”(physical association)0.560
NOL4TEX9psi-mi:“MI:0915”(physical association)0.560
TEX9PPP1R13Bpsi-mi:“MI:0915”(physical association)0.560
GSTA5TEX9psi-mi:“MI:0915”(physical association)0.560
TXNDC9TEX9psi-mi:“MI:0915”(physical association)0.560
TEX9CCHCR1psi-mi:“MI:0915”(physical association)0.560
TEX9NXF1psi-mi:“MI:0915”(physical association)0.560
TEX9NOL4psi-mi:“MI:0914”(association)0.530
DISC1AP4M1psi-mi:“MI:0914”(association)0.530
CCDC148SCGB2A1psi-mi:“MI:0914”(association)0.350
CDK5RAP2PDHXpsi-mi:“MI:0914”(association)0.350
SYCE1RABGAP1Lpsi-mi:“MI:0914”(association)0.350
CEP128CCDC66psi-mi:“MI:2364”(proximity)0.270
PCM1CCDC66psi-mi:“MI:2364”(proximity)0.270
CEP135CCDC66psi-mi:“MI:2364”(proximity)0.270
SPICE1CCDC66psi-mi:“MI:2364”(proximity)0.270
CEP63CCDC66psi-mi:“MI:2364”(proximity)0.270
TEX9NOL4psi-mi:“MI:0915”(physical association)0.000

BioGRID (58): TEX9 (Affinity Capture-MS), CCDC112 (Affinity Capture-MS), NOL4L (Affinity Capture-MS), NOL4 (Affinity Capture-MS), TEX9 (Two-hybrid), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), TEX9 (Proximity Label-MS), NOL4 (Affinity Capture-MS), NOL4L (Affinity Capture-MS), CCDC112 (Affinity Capture-MS), TEX9 (Affinity Capture-MS), GOLGA2 (Two-hybrid)

ESM2 similar proteins: A0JMA8, A0MZ66, A0MZ67, A1A5P5, A4IGC3, A5WW21, B3DLE8, H2MTR9, P70302, P84903, Q08DR9, Q0P4J3, Q13586, Q16206, Q28IH8, Q2TAA8, Q3KR99, Q4R6I5, Q5BIX7, Q5I033, Q5M8Y7, Q5RA03, Q5U245, Q5XG48, Q5XIR8, Q6GP65, Q6IP02, Q6IQY5, Q6NRK1, Q6NRW2, Q6NRX3, Q6P0R8, Q6P402, Q7T0S7, Q7Z3E5, Q8BXX9, Q8K2Q9, Q8K4I6, Q8MJK1, Q8N6V9

Diamond homologs: Q8N6V9, Q9D845

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

83 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance63
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2981 predictions. Top by Δscore:

VariantEffectΔscore
15:56365671:G:GGdonor_gain1.0000
15:56373440:GGC:Gacceptor_gain1.0000
15:56373500:TAATA:Tdonor_gain1.0000
15:56373501:AATA:Adonor_gain1.0000
15:56373501:AATAG:Adonor_loss1.0000
15:56373502:ATA:Adonor_gain1.0000
15:56373502:ATAG:Adonor_loss1.0000
15:56373503:TA:Tdonor_gain1.0000
15:56373503:TAG:Tdonor_loss1.0000
15:56373504:AGT:Adonor_loss1.0000
15:56373505:G:GGdonor_gain1.0000
15:56373506:T:TCdonor_loss1.0000
15:56373507:AAG:Adonor_loss1.0000
15:56373508:AG:Adonor_loss1.0000
15:56383922:T:Gacceptor_gain1.0000
15:56388462:T:TAacceptor_gain1.0000
15:56389313:T:Gacceptor_gain1.0000
15:56389316:A:AGacceptor_gain1.0000
15:56389317:G:GGacceptor_gain1.0000
15:56389317:GCCAA:Gacceptor_gain1.0000
15:56391241:A:AGacceptor_gain1.0000
15:56391242:G:GGacceptor_gain1.0000
15:56391242:GT:Gacceptor_gain1.0000
15:56391355:G:GTdonor_gain1.0000
15:56391397:GTT:Gdonor_gain1.0000
15:56391834:T:Gacceptor_gain1.0000
15:56394833:GG:Gdonor_gain1.0000
15:56394834:GG:Gdonor_gain1.0000
15:56412407:GAGT:Gdonor_gain1.0000
15:56412410:T:Gdonor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000023636 (15:56344119 A>G), RS1000024274 (15:56395093 A>G), RS1000027518 (15:56308715 A>G), RS1000038527 (15:56261577 G>A), RS1000051844 (15:56423991 C>G,T), RS1000081094 (15:56430176 A>C), RS1000102824 (15:56439771 A>G), RS1000111862 (15:56261368 A>T), RS1000119776 (15:56305756 G>A,T), RS1000135877 (15:56436313 C>T), RS1000170264 (15:56305396 A>C,G), RS1000175712 (15:56391065 A>G), RS1000208409 (15:56436166 C>T), RS1000223830 (15:56275104 G>A), RS1000237738 (15:56272602 T>G)

Disease associations

OMIM: gene MIM:620935 | disease phenotypes: MIM:618948

GenCC curated gene-disease

Mondo (1): heterotaxy, visceral, 9, autosomal, with male infertility (MONDO:0030070)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

24 associations (top):

StudyTraitp-value
GCST002183_9Relative hand skill in reading disability4.000000e-06
GCST002595_8Clozapine-induced agranulocytosis9.000000e-07
GCST004602_211Mean corpuscular volume5.000000e-11
GCST004621_77Red cell distribution width3.000000e-15
GCST004630_160Mean corpuscular hemoglobin2.000000e-09
GCST006804_40Red cell distribution width9.000000e-14
GCST008962_7Hematology traits1.000000e-08
GCST008962_8Hematology traits2.000000e-08
GCST90002390_414Mean corpuscular hemoglobin2.000000e-31
GCST90002392_427Mean corpuscular volume3.000000e-37
GCST90002396_634Mean reticulocyte volume6.000000e-31
GCST90002397_256Mean spheric corpuscular volume2.000000e-28
GCST90002403_481Red blood cell count3.000000e-10
GCST90002404_364Red cell distribution width1.000000e-39
GCST90020024_485A body shape index2.000000e-09
GCST90020024_487A body shape index3.000000e-11
GCST90020025_127Waist-to-hip ratio adjusted for BMI3.000000e-09
GCST90020025_129Waist-to-hip ratio adjusted for BMI1.000000e-11
GCST90020025_130Waist-to-hip ratio adjusted for BMI4.000000e-08
GCST90020027_633Waist-hip index9.000000e-10
GCST90020027_635Waist-hip index1.000000e-11
GCST90020027_636Waist-hip index1.000000e-08
GCST90020029_293Waist circumference adjusted for body mass index5.000000e-12
GCST90020029_296Waist circumference adjusted for body mass index1.000000e-09

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0009902handedness
EFO:0009188Red cell distribution width
EFO:0004527mean corpuscular hemoglobin
EFO:0004348hematocrit
EFO:0004509hemoglobin measurement
EFO:0010701mean reticulocyte volume
EFO:0004305erythrocyte count
EFO:0007789BMI-adjusted waist circumference
EFO:0007788BMI-adjusted waist-hip ratio

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression6
Cyclosporinedecreases expression, decreases methylation, increases expression3
perfluorooctane sulfonic aciddecreases expression2
Vorinostataffects cotreatment, increases expression2
aristolochic acid Idecreases expression1
sotorasibaffects cotreatment, increases expression1
triphenyl phosphateaffects expression1
beta-lapachonedecreases expression1
arseniteaffects expression1
sodium arseniteaffects methylation1
S-(1,2-dichlorovinyl)cysteineaffects cotreatment, decreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
dorsomorphinincreases expression, affects cotreatment1
jinfukangdecreases expression, affects cotreatment, increases expression1
incobotulinumtoxinAincreases expression1
trametinibaffects cotreatment, increases expression1
NVP-BKM120affects cotreatment, increases expression1
Acetaminophenincreases expression1
Azathioprinedecreases expression1
Cisplatinaffects cotreatment, increases expression1
Clorgylineincreases expression1
Doxorubicinincreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Lipopolysaccharidesaffects cotreatment, decreases expression1
Methyl Methanesulfonateincreases expression1
Phthalic Acidsincreases methylation1
Quercetindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.